Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 876, Issue , 1999, Pages 131-144

  Østensen, Monika ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INTERLEUKIN 10; INTERLEUKIN 4; PHOSPHOLIPID ANTIBODY; PROGESTERONE; PROLACTIN; SEX HORMONE;

AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONFERENCE PAPER; DISEASE COURSE; FEMALE; FEMALE FERTILITY; FETUS WASTAGE; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYPERPROLACTINEMIA; IMMUNE RESPONSE; LACTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; PREGNANCY; RELAPSE; RHEUMATOID ARTHRITIS; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032781755     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07630.x     Document Type: Conference Paper

References (95)

1. 1. WILDER, R. L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13: 307-338.
2. 2. PETRI, M. & C. ROBINSON. 1997. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum. 40: 797-803.
3. 3. HOCHBERG, M. C. 1990. Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin. Arthritis Rheum. 19: 294-302.
4. 4. WINCHESTER, R. 1994. The molecular basis of susceptibility to rheumatoid arthritis. Adv. Immunol. 56: 389-466.
5. 5. KAY, A. & F. BACH. 1965. Subfertility before and after the development of rheumatoid arthritis in women. Ann. Rheum. Dis. 24: 169-173.
6. 6. NELSON, J. L., T. D. KOEPSELL, C. E. DUGOWSON, et al. 1993. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum. 36: 7-14.
7. 7. HENCH, P. S. 1938. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Proc. Staff Meet. Mayo Clin. 13: 161-167.
8. 8. OKA, M. 1953. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann. Rheum. Dis. 12: 227-229.
9. 9. BETSON, J. R. & R. V. DORN. 1964. Forty cases of arthritis and pregnancy. J. Int. College Surg. 42: 521-526.
10. 10. MORRIS, W. I. C. 1969. Pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Aust. N. Z. J. Obstet. Gynaecol. 9: 136-144.
11. 11. NEELY, N. T. & R. H. PERSELLIN. 1977. Activity of rheumatoid arthritis during pregnancy. Texas Med. 73: 59-63.
12. 12. ØSTENSEN, M., B. AUNE, & G. HUSBY. 1983. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand. J. Rheumatol. 12: 69-72.
13. 13. SMITH, W. D. & H. F. WEST. 1960. Pregnancy and rheumatoid arthritis. Acta Rheum. Scand. 6: 189-201.
14. 14. ØSTENSEN, M. & G. HUSBY. 1983. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 26: 1155-1159.
15. 15. UNGER, A., A. KAY, A. J. GRIFFIN & G. S. PANAYI. 1983. Disease activity and pregnancy associated α2-glycoprotein in rheumatoid arthritis during pregnancy. Br. Med. J. 286: 750-752.
16. 16. NELSON, J. L., K. A. HUGHES, A. G. SMITH, et al. 1993. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N. Engl. J. Med. 329: 466-471.
17. 17. KAY, A., A. UNGER & J. GRIFFIN. 1986. Interaction of pregnancy and disease. Br. J. Rheumatol. Suppl. 25: SA1.
18. 18. POPE, R. M., S. YOSHINOYA, J. RUTSTEIN, R. H. PERSELLIN. 1983. Effect of pregnancy on immune complexes and rheumatoid factors in patients with rheumatoid arthritis. Am. J. Med. 74: 973-979.
19. 19. NELSON, J. L. & M. ØSTENSEN. 1997. Pregnancy and rheumatoid arthritis. Rheum. Dis. Clin. North Am. 23: 195-212.
20. 20. SKOMSVOLL, J. F., M. ØSTENSEN, L. M. IRGENS & V. BASTE. 1998. Obstetrical and neonatal outcome in pregnant patients with rheumatic disease. Scand. J. Rheumatol. Suppl. 107: 109-112.
21. 21. OKA, M. & U. VAINIO. 1966. Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheumatol. Scand. 12: 47-52.
22. 22. ØSTENSEN, M. & H. ØSTENSEN. 1996. Safety of nonsteroidal antiinflammatory drugs in pregnant patients with rheumatic disease. J. Rheumatol. 23: 1045-1049.
23. 23. HAZES, J. M. W., B. A. C. DUKMANS, J. P. VANDENBROUCKE, R. R. P. DE VRIES & A. CATS. 1990. Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum. 33: 1770-1775.
24. 24. SPECTOR, T. D., E. ROMAN & A. J. SILMAN. 1990. The pill, parity, and rheumatoid arthritis. Arthritis Rheum. 33: 782-789.
25. 25. DUGOWSON, C. W., J. L. NELSON, T. D. KOEPSELL, L. F. VOIGT & J. R. DALING. 1991. Nulliparity as a risk factor for rheumatoid arthritis. Arthritis Rheum. 34: S48 [abstract].
26. 26. BRUN, J. G., S. NILSSEN & G. KVALE. 1995. Breast feeding, other reproductive factors and rheumatoid arthritis. A prospective study. Br. J. Rheumatol. 34: 542-546.
27. 27. HELIÖVAARA, M., K. AHO, A. REUNANEN, P. KNEKT & A. AROMAA. 1995. Parity and risk of rheumatoid arthritis in Finnish women. Br. J. Rheumatol. 34: 625-628.
28. 28. KOEPSELL, T. D., C. E. DUGOWSON, L. F. VOIGT, J. L. NELSON & J. R. DALING. 1990. Reduced incidence of rheumatoid arthritis during pregnancy. Arthritis Rheum. 33: S29 [abstract].
29. 29. SILMAN, A., A. KAY & P. BRENNAN. 1992. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 35: 152-155.
30. 30. LANSINK, M., A. DE BOER, B. DUKMANS, J. VANDENBROUCKE & J. HAZES. 1993. The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin. Exp. Rheumatol. 11: 171-174.
31. 31. BRENNAN, P. & A. SILMAN. 1994. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum. 37: 808-813.
32. 32. PERSELLIN, R. H., D. WIGINTON, J. RUTSTEIN, et al. 1982. Pregnancy alpha-glycoprotein (PAG) and rheumatoid arthritis (RA) activity: A prospective analysis during gestation. Arthritis Rheum. 25(S): S6-21.
33. 33. QUINN, C., K. MULPETER, E. CASEY & C. FEIGHERY. 1993. Changes in levels of IgM RF and α-2 PAG correlate with increased disease activity in rheumatoid arthritis during the puerperium. Scand. J. Rheumatol. 22: 273-279.
34. 2-pregnancy-associated globulin and activity of rheumatoid arthritis and ankylosing spondylitis during pregnancy. Scand. J. Rheumatol. 12: 315-318.
35. 35. ROOK, G., J. STEELE, R. BREALEY, et al. 1991. Changes in IgG glycoform levels may be relevant to remission of arthritis during pregnancy. J. Autoimmunity 4: 779-794.
36. 36. WEGMANN, T. G., H. LIN, L. GUILBERT & T. R. MOSMANN. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14: 353-356.
37. 37. CHAOUAT, G., J. TRANCHOT DIALLO, J. LUC VOLUMENE, et al. 1996. Immune suppression and TH1/TH2 balance in pregnancy revisited: A very personal tribute to Tom Wegmann. Am. J. Reprod. Immunol. 37: 427-434.
38. 38. RUSSEL, A. S., C. JOHNSTON, C. CHEW & W. P. MAKSYMOWYCH. 1997. Evidence for reduced Th1 function in normal pregnancy: A hypothesis for the remission of rheumatoid arthritis. J. Rheumatol. 24: 1045-1050.
39. 39. AUSTGULEN, R., K. J. ARNTZEN & R. ØDEGAARD. 1998. Circulating levels of cytokines and cytokine receptors in normal human pregnancy. Scand. J. Rheumatol. 27 (Suppl. 107): 18.
40. 40. AUSTGULEN, R., N. B. LIABAKK, E. LIEN & T. ESPEVIK. 1993. Increased levels of soluble tomor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr. Res. 33: 82-87.
41. 41. RUSSEL, A. S. 1998. Immune modulation (TH1 and TH2 responses) in pregnancy. Scand. J. Rheumatol. 27 (Suppl. 107): 14-17.
42. 42. SZEKERES-BARTHO, J., G. PAR, L. SZEREDAY, et al. 1997. Progesterone and non-specific immunologic mechanisms in pregnancy. Am. J. Reprod. Immunol. 38: 176-182.
43. 43. SZEREDAY, L., P. VARGA & J. SZEKERES-BARTHO. 1997. Cytokine production by lymphocytes in pregnancy. Am. J. Reprod. Immunol. 38: 418-422.
44. 44. SABAHI, F., M. ROLA-PLECZYCYNSKI, S. O'CONNELL & L. D. FRENKEL. 1995. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am. J. Reprod. Immunol. 33: 381-392.
45. 45. EKERFELT, C., L. MATTHIESEN, G. BERG & J. ERNERUDH. 1997. Paternal leukocytes selectively increase secretion of II-4 in peripheral blood during normal pregnancies: Demonstrated by a novel, one-way MLC measuring cytokine secretion. Am. J. Reprod. Immunol. 38: 320-326.
46. 46. HOOPER, D. SHEPPS, R. SOOD, D. COFFIN & R. LOONEY. 1996. The effect of pregnancy on production of cytokines by peripheral blood cells from patients with rheumatoid arthritis. Arthritis Rheum. 39: 1017.
47. 47. ELENKOV, I. J., J. HOFFMAN & R. L WILDER. 1997. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol. Med. Today 3: 379-383.
48. 48. CHIKANZA, I. C., P. PETROU, G. CHROUSOS, G. KINGSLEY & G. PANAYI. 1993. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br. J. Rheumatol. 32: 445-448.
49. 49. WHYTE, A. & R. O. WILLIAMS. 1988. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum. 31: 927-928.
50. 50. MATTSON, R., A. MATTSON, R. HOLMDAHL, et al. 1991. Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin. Exp. Immunol. 85: 41-47.
51. 51. JOSEFSSON, E. & A. TARKOWSKI. 1997. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum. 40: 154-163.
52. 52. SIEGEL, M. & S. L. LEE. 1973. The epidemiology of systemic lupus erythematosus. Semin. Arthritis Rheum. 3: 1-54.
53. 53. ROOD, M. J., E. A. VAN DER VELDE, R. TEN CATE, et al. 1998. Female sex hormones at the onset of systemic lupus erythematosus affect survival. Br. J. Rheumatol. 37: 1008-1010.
54. 54. FRAGA, A., G. MINTZ, J. OROZCO & J. H. OROZCO. 1974. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J. Rheumatol. 1: 293-298.
55. 55. NOSSENT, H. C. & T. J. G. SWAAK. 1990. Systemic lupus erythematosus VI. Analysis of the interrelationship with pregnancy. J. Rheumatol. 17: 771-776.
56. 56. BOUMPAS, D. T., H. A. AUSTIN, E. M. VAUGHAN, et al. 1993. Risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann. Intern. Med. 119: 366-369.
57. 57. CECERE, F. & R. H. PERSELLIN. 1981. The interaction of pregnancy and the rheumatic diseases. Clin. Rheum. Dis. 7: 747-768.
58. 58. GARSENSTEIN, M., V. E. POLLAK & R. M. KARK. 1962. Systemic lupus erythematosus and pregnancy. N. Engl. J. Med. 267: 165-169.
59. 59. KHAMASHTA, M. A., G. RUIZ-IRASTORZA & G. R. V. HUGHES. 1997. Systemic lupus erythematosus flares during pregnancy. Rheum. Dis. Clin. North Am. 23: 15-29.
60. 60. LOCKSHIN, M. D., E. REINITZ, M. L. DRUZIN, M. MURMAN & D. ESTES. 1984. Lupus pregnancy: Case-control study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med. 77: 893-898.
61. 61. MINTZ, G., J. NIZ, G. GUTIERREZ, A. GARCIA-ALONSO & S. KARCHMER. 1986. Prospective study of pregnancy in systemic lupus erythematosus. Results of multidisciplinary approach. J. Rheumatol. 13: 732-739.
62. 62. UROWITZ, M. B., D. D. GLADMAN, V. T. FAREWELL, J. STEWART & J. MCDONALD. 1993. Lupus and pregnancy studies. Arthritis Rheum. 36: 1392-1397.
63. 63. WONG, K. L., F. Y. CHAN & C. P. LEE. 1991. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch. Int. Med. 151: 269-273.
64. 64. PETRI, M., D. HOWARD & J. REPKE, 1991. Frequency of lupus flare during pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34: 1538-1545.
65. 65. RUIZ-IRASTORZA, G., F. LIMA, J. ALVES, et al. 1996. Increased rate of lupus flare during pregnancy and the puerperium. Br. J. Rheumatol. 35: 133-138.
66. 66. TINCANI, A., D. FADEN, M. TARANTINI, et al. 1992. Systemic lupus erythematosus and pregnancy: A prospective study. Clin. Exp. Rheumatol. 10: 439-446.
67. 67. YELL, J. A. & S. M. BURGE. 1993. The effect of hormonal changes on cutaneous lupus erythematosus. Br. J. Dermatol. 129: 18-22.
68. 68. HAYSLETT, J. P. & R. I. LYNN. 1980. Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 18: 207-220.
69. 69. OVASIU, E., J. HICKS & J. S. CAMERON. 1991. The outcome of pregnancy in women with lupus nephritis. Lupus 1: 19-25.
70. 70. JULKUNEN, H., R. KAAIA, T. PALOSUO, C. GRÖNHAGEN-RISKA & K. TERAMO. 1993. Pregnancy in lupus nephropathy. Acta Obstet. Gynecol. Scand. 72: 258-263.
71. 71. PACKHAM, D. K., S. S. LAM, K. NICHOLLS, K. F. FAIRLEY & P. S. KINCAID-SMITH. 1992. Lupus nephritis and pregnancy. Q. J. Med. 83: 315-324.
72. 72. BUYON, J. P., J. TAMERIUS, S. ORDORICA, B. YOUNG & S. B. ABRAHAMSON. 1992. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum. 72: 258-263.
73. 73. LE THI HUONG, D., B. WECHSLER, J. C. PIETTE, et al. 1994. Pregnancy and its outcome in systemic lupus erythematosus. Q. J. Med. 87: 721-729.
74. 74. PETRI, M. & J. ALLBRITTON. 1993. Fetal outcome of lupus pregnancy: A retrospective case-control study of the Hopkins Lupus Cohort. J. Rheumatol. 20: 650-656.
75. 75. LIMA, F., N. M. M. BUCHANAN, M. A. KHAMASHTA, et al. 1995. Obstetric outcome in systemic lupus erythematosus. Semin. Arthritis Rheum. 25: 184-192.
76. 76. BUYON, J. P. 1996. Neonatal lupus: Bedside to bench and back. Scand. J. Rheumatol. 25: 271-276.
77. 77. TSENG, C. E. & J. P. BUYON. 1997. Neonatal lupus syndromes. Rheum. Dis. Clin. North Am. 23: 31-54.
78. 78. BRANCH, D. W., J. R. SCOTT, N. K. KOCHENOUR, et al. 1985. Obstetric complications associated with the lupus anticoagulant. N. Engl. J. Med. 313: 1322-1326.
79. 79. SILVER, R. M. & D. W. BRANCH. 1997. Autoimmune disease in pregnancy. Clin. Perinatol. 24: 291-320.
80. 81. SALAFIA, C. S. & A. L. PARKE. 1997. Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum. Dis. Clin. North Am. 23: 85-97.
81. 80. ABRAMOSKY, C. R., M. E. VEGAS, G. SWINEHART, et al. 1980. Decidual vasculopathy of the placenta in systemic lupus erythematosus. N. Engl. J. Med. 303: 668-672.
82. 82. LAHITA, R. G. 1992. The effect of sex hormones on the immune system in pregnancy. Am. J. Reprod. Immunol. 28: 136-137.
83. 83. CUTOLO, M., A. SULLI, A. BAROLE, et al. 1996. Sex hormones, proto-oncogene expression and apoptosis: Their effects on rheumatoid synovial tissue. Clin. Exp. Rheumatol. 14: 87-94.
84. 84. EVANS, M. J., S. MACLAUGHLIN, R. D. MARVIN, et al. 1997. Estrogen decreases in vitro apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin. Immunol. Immunopathol. 82: 258-262.
85. 85. ROUBINIAN, J., N. TALAI, P. K. SITTERI & J. A. SADAKIAN. 1979. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 22: 1162-1169.
86. 86. LAHITA, R. G., H. L. BRADLOW, H. G. KUNKEL & J. FISHMAN. 1981. J. Clin. Endocrinol. Metab. 53: 174-178.
87. 87. FOLOMEEV, M., M. DOUGADOS, J. BEAUNE, et al. 1992. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1: 191-195.
88. 88. SHAH, N. N., C. A. FAALAND, T. THOMAS, et al. 1996. Estradiol analogues and polyamines alter the binding affinity of estrogen receptor (ER) with estrogen response element (ERE): Potential implications for estrogenic action in lupus. Arthritis Rheum. 36 (Suppl.): S109.
89. 89. RATKAY, L. G., D. ZHANG, J. TONZETICH, et al. 1994. Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions. Clin. Exp. Immunol. 98: 52-59.
90. 90. LAVALLE, C., A. GRAEF, V. BACA, et al. 1993. Prolactin and gonadal hormones: A key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus. Lupus 2: 71-75.
91. 91. WALKER, S., R. W. MCMURRAY, J. M. HOURI, et al. 1998. Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 840: 762-772.
92. 92. JARA-QUEZADA, L., A. GRAEF & C. LAVALLE. 1991. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J. Rheumatol. 18: 349-353.
93. 93. PETRI, M. & D. CHAN. 1995. Longitudinal analysis of prolactin and disease activity in SLE pregnancy. Arthritis Rheum. 38 (Suppl.): S220.
94. 94. MCMURRAY, R. W., D. KEISLER, S. IZUI & S. E. WALKER. 1993. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J. Rheumatol. 20: 1143-1151.
95. 95. MCMURRAY, R. W., D. KEISLER, K. KANUCKEL, S. IZUI & S. E. WALKER. 1991. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 147: 3780-3787.